Children's Cancer Institute

Last updated

Children's Cancer Institute
CCI CMYK.jpg
MottoCuring childhood cancer. It's not if. It's when.
Established1976;44 years ago (1976)
Mission Translational medical research
Focus Childhood cancer
Executive Director Michelle Haber AM
Faculty University of New South Wales
Adjunct faculty Sydney Children's Hospital
Staffapprox. 200
Location
Level 5, C25 Lowy Cancer Research Centre, High Street, Randwick
, , ,
Australia
Coordinates 33°55′00″S151°14′08″E / 33.916643°S 151.235606°E / -33.916643; 151.235606 Coordinates: 33°55′00″S151°14′08″E / 33.916643°S 151.235606°E / -33.916643; 151.235606
Website ccia.org.au

Children's Cancer Institute is an Australian medical research institute wholly dedicated to the prevention and treatment of childhood cancer. [1] Established in 1976, the Institute is affililiated with both the University of New South Wales and Sydney Children's Hospital and is located in Randwick, Sydney, New South Wales.

Contents

The Institute's vision is to save the lives of all children with cancer and improve the quality of life for survivors; and is led by Professor Michelle Haber AM since its establishment. [1]

History

In 1975, Jack Kasses and John Lough met in the waiting room of Sydney Children's Hospital where their daughter and son respectively were undergoing treatment for leukaemia. Lough approached the Apex Club in Wollongong to raise money for cancer research. They started the "Help a Kid Make It" campaign – with a target of $1 million to facilitate research into childhood cancer. [2]

The Children’s Leukaemia and Cancer Foundation was established in May 1976. The foundation evolved into Children's Cancer Institute, which opened its own research laboratories in 1984. The first scientists to join the Institute were Haber, who is now the Executive Director, Murray Norris AM , now the Deputy Director, and Maria Kavallaris, now Program Head, Tumour Biology & Targeting.

Research focus

The Institute is grouped into four main research units focused on the prevention and treatment of childhood cancer and include understanding childhood cancer, improving diagnosis, finding better treatments, and improving life after cancer.

Achievements

Fundraising initiatives

The Institute undertakes a range of fundraising initiatives including 'Build for a Cure', where a newly-constructed and fully furnished home in Glenmore Park was sold at auction in 2014 for A$783,000. Scott Cam was an ambassador for the initiative. [9] [10] [11]

The Institute is also the beneficiary of many events held annually throughout Australia. [12] [13] [14] [15]

See also

Related Research Articles

Leukemia Group of blood cancers that usually begin in the bone marrow

Leukemia, also spelled leukaemia, is a group of blood cancers that usually begin in the bone marrow and result in high numbers of abnormal blood cells. These blood cells are not fully developed and are called blasts or leukemia cells. Symptoms may include bleeding and bruising, fatigue, fever, and an increased risk of infections. These symptoms occur due to a lack of normal blood cells. Diagnosis is typically made by blood tests or bone marrow biopsy.

Tumors of the hematopoietic and lymphoid tissues

Tumors of the hematopoietic and lymphoid tissues or tumours of the haematopoietic and lymphoid malignancies are tumors that affect the blood, bone marrow, lymph, and lymphatic system. Because these tissues are all intimately connected through both the circulatory system and the immune system, a disease affecting one will often affect the others as well, making myeloproliferation and lymphoproliferation closely related and often overlapping problems.

Acute lymphoblastic leukemia Blood cancer characterised by overproduction of lymphoblasts

Acute lymphoblastic leukemia (ALL) is a cancer of the lymphoid line of blood cells characterized by the development of large numbers of immature lymphocytes. Symptoms may include feeling tired, pale skin color, fever, easy bleeding or bruising, enlarged lymph nodes, or bone pain. As an acute leukemia, ALL progresses rapidly and is typically fatal within weeks or months if left untreated.

CLIC Sargent

CLIC Sargent is a charity in the United Kingdom formed in 2005. CLIC Sargent is the UK's leading cancer charity for children, young people and their families. Its care teams provide specialist support across the UK.

Neuroblastoma

Neuroblastoma (NB) is a type of cancer that forms in certain types of nerve tissue. It most frequently starts from one of the adrenal glands but can also develop in the neck, chest, abdomen, or spine. Symptoms may include bone pain, a lump in the abdomen, neck, or chest, or a painless bluish lump under the skin.

History of cancer chemotherapy

The era of cancer chemotherapy began in the 1940s with the first use of nitrogen mustards and folic acid antagonist drugs. The targeted therapy revolution has arrived, but many of the principles and limitations of chemotherapy discovered by the early researchers still apply.

Teniposide

Teniposide is a chemotherapeutic medication used in the treatment of childhood acute lymphocytic leukemia (ALL), Hodgkin's lymphoma, certain brain tumours, and other types of cancer. It is in a class of drugs known as podophyllotoxin derivatives and slows the growth of cancer cells in the body.

Blood Cancer UK

Blood Cancer UK, is a UK-based charity dedicated to funding research into all blood cancers including leukaemia, lymphoma and myeloma, as well as offering information and support to blood cancer patients.

The Children’s Cancer and Leukaemia Group is an organization focused on childhood cancer. The organization was formed on 1 August 2006, as a result of the merger of the United Kingdom Children's Cancer Study Group (UKCCSG) and the UK Childhood Leukaemia Working Party.

Minimal residual disease (MRD) is the name given to small numbers of leukaemic cells that remain in the person during treatment, or after treatment when the patient is in remission. It is the major cause of relapse in cancer and leukemia. Up until a decade ago, none of the tests used to assess or detect cancer were sensitive enough to detect MRD. Now, however, very sensitive molecular biology tests are available, based on DNA, RNA or proteins. These can measure minute levels of cancer cells in tissue samples, sometimes as low as one cancer cell in a million normal cells.

The Band of Parents is a 501c3 nonprofit organization. Formed in July 2007 and incorporated in October 2007, it was founded by approximately 100 parents of young children with neuroblastoma who were treated at Memorial Sloan Kettering Cancer Center (MSKCC). Its purpose is to fund the development of new therapies for neuroblastoma that would not otherwise be pursued by research institutions or the pharmaceutical industry. The organization has become the largest single funder of neuroblastoma research at MSKCC.

Donald Pinkel American Medical Doctor

Donald Paul Pinkel is an American medical doctor who specializes in pediatric hematology and oncology. He was born in Buffalo, New York and graduated from Canisius High School in 1944. He has made contributions to cures for several forms of childhood cancer, including leukemia. He has received many awards and recognitions for his research work, including the Albert Lasker Award for Clinical Medical Research in 1972, the Kettering Prize for cancer research in 1986, and the Pollin Prize for Pediatric Research in 2003. Pinkel was the first director of St. Jude Children's Research Hospital in Memphis, Tennessee, serving from 1962 to 1973. He has also authored or co-authored numerous books, chapters in books, and journal articles.

Childhood leukemia

Childhood leukemia is leukemia that occurs in a child and is a type of childhood cancer. Childhood leukemia is the most common childhood cancer, accounting for 29% of cancers in children aged 0–14 in 2018. There are multiple forms of leukemia that occur in children, the most common being acute lymphoblastic leukemia (ALL) followed by acute myeloid leukemia (AML). Survival rates vary depending on the type of leukemia, but may be as high as 90% in ALL.

Neuroblastoma Childrens Cancer Alliance UK

The Neuroblastoma Children's Cancer Alliance UK, commonly referred to as NCCA UK, is a UK charity that helps children and families affected by neuroblastoma, a type of childhood cancer. The charity helps families by helping them to access and fundraise for their child's treatment abroad when no treatment is available in the UK, offering support and funding research into the condition.

Michelle Haber is an Australian cancer researcher.

Entrectinib

Entrectinib, sold under the brand name Rozlytrek, is an anti-cancer medication used to treat ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. It is a selective tyrosine kinase inhibitor (TKI), of the tropomyosin receptor kinases (TRK) A, B and C, C-ros oncogene 1 (ROS1) and anaplastic lymphoma kinase (ALK).

Ren Michael Pedersen 4 February 1971 in Atherton, North Queensland, Australia.

Childrens Cancer Foundation (Australia)

The Children's Cancer Foundation is a registered Australian charity that supports children with cancer and their families.

Maria Kavallaris is an Australian scientist, based at the University of New South Wales' Children's Cancer Institute, where she is best known for her contributions to the field of cancer research. On 25 January 2019, Kavallaris was appointed a member of the Order of Australia.

Christine J. Harrison is a Professor of Childhood Cancer Cytogenetics at Newcastle University. She works on acute leukemia, and used cytogenetics to optimise treatment protocols.

References

  1. 1 2 "Our purpose". Children's Cancer Institute. Retrieved 5 September 2016.
  2. "Annual Report 2014-2015" (PDF). The Apex Foundation. 2015. Archived from the original (PDF) on 25 November 2015.
  3. Alexander, H (2 September 2015). "Australian-first program aims to eliminate childhood cancer deaths". The Sydney Morning Herald . Retrieved 25 November 2015.
  4. Corderoy, A (10 July 2015). "New drug brings hope for child leukaemia patients". The Age . Retrieved 25 November 2015.
  5. "Australian scientists make discovery that could stop neuroblastoma, the worst childhood cancer" (radio program). ABC Radio. Sydney. 5 November 2015. Retrieved 25 November 2015.
  6. Dunlevy, S (1 September 2014). "Rejected drug now helps kids". The Daily Telegraph. Australia. p. 12.
  7. "Seven News at 4:30". Channel 7 (television program). Sydney. 12 March 2013.
  8. Davey, M (13 March 2013). "Genetic research doubles leukaemia survival rate". The Sydney Morning Herald . p. 14.
  9. "A Current Affair". A Current Affair (television program). Sydney. 27 October 2014. Nine Network.
  10. Clark, C (16 October 2014). "Stars help build for a cure". The Daily Telegraph. Australia. Retrieved 25 November 2015.
  11. Georgopoulos, M (27 October 2014). "Build for a Cure home in Glenmore Park goes for $783,000 at auction". News.com.au. Retrieved 25 November 2015.
  12. "Breakfast with Michael Clarke". ABC North Queensland (radio program). Townsville. 23 July 2015.
  13. King, R (26 March 2015). "Diving in to help sick kids". Mosman Daily. p. 22.
  14. Mayoh, L (17 October 2015). "Fun in fighting the good fight". The Daily Telegraph. Australia. p. 3.
  15. Tarbert, K (5 June 2015). "Heroism shown by Zoe in disease fight inspires mum to run". Penrith Press. Retrieved 2 December 2015.